Skip to main content

CORRECTION article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1483043
This article is part of the Research Topic Novel Approaches for Immunotherapy of Lymphoma View all 4 articles

Corrigendum: Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

Provisionally accepted
  • 1 Institute of Haematology and Blood Transfusion (Czechia), Prague, Czechia
  • 2 Faculty of Science, Charles University, Prague, Prague, Czechia

The final, formatted version of the article will be published soon.

    Keywords: CAR-T cells, Leukemia, Lymphoma, Electroporation, PiggyBac PB transposon

    Received: 19 Aug 2024; Accepted: 21 Aug 2024.

    Copyright: © 2024 Mucha, Štach, Kaštánková, Rychlá, Vydra, Lesný and Otáhal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Martin Mucha, Institute of Haematology and Blood Transfusion (Czechia), Prague, Czechia
    Pavel Otáhal, Institute of Haematology and Blood Transfusion (Czechia), Prague, Czechia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.